Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases.



Status:Completed
Conditions:Alzheimer Disease, Parkinsons Disease, Hospital, Hospital, Neurology, Neurology, Neurology, Neurology, Neurology, Neurology, Orthopedic, Multiple Sclerosis
Therapuetic Areas:Neurology, Orthopedics / Podiatry, Other
Healthy:No
Age Range:18 - Any
Updated:9/28/2018
Start Date:July 2016
End Date:August 2018

Use our guide to learn which trials are right for you!

A Single-Arm Prospective Investigation of the Effects of Laughter Therapy on Mood, Stress, and Self-Efficacy in People With Central Nervous System Disorders.

This is a prospective investigation of the effects of Laughter therapy (LT) on perceived
stress, self-efficacy, mood and other wellness measures in people with the following
neurological conditions: Alzheimer's disease, amyotrophic lateral sclerosis, brain injury,
Huntington's Disease, multiple sclerosis, Parkinson's Disease, post-stroke, spinal cord
injury.

Laughter therapy (LT) has potential benefits in treating illness. It combines laughter with
breathing and body exercises to stimulate laughter, both real and artificial, in a group
setting. Laughter therapy may help treating illness by strengthening breathing muscles,
improving mood, and providing pain and stress relief. EvergreenHealth has presented laughter
therapy classes to patients with Parkinson's disease and Multiple sclerosis and other
neurological conditions. The therapy will be led by a certified laughter therapist and mental
health professional.

Inclusion Criteria:

- Diagnosis based on medical record review of one of the following neurological
diseases: Alzheimer's disease, amyotrophic lateral sclerosis, brain injury,
Huntington's Disease, Multiple Sclerosis, Parkinson's Disease, Post-Stroke, Spinal
Cord Injury.

- Medically stable for at least 2 months.

- Not participating in Laughter therapy for 30 days prior to screening.

Exclusion Criteria:

- Females who are pregnant

- Any unstable medical condition

- Severe cognitive deficits that would interfere with participation (e.g. unable to
follow commands).

- Severe abdominal pain, chest pain or back pain.

- Abdominal, chest or back surgery within 90 days.

- Psychosis or severe mental illness.

- Untreated hernia.

- Persistent cough.

- Advanced hemorrhoids.

- Epilepsy.

- Uncontrolled Hypertension - SBP >170 or DBP >105.
We found this trial at
1
site
Kirkland, Washington 98034
Principal Investigator: Theodore R Brown, MD, MPH
Phone: 425-899-5393
?
mi
from
Kirkland, WA
Click here to add this to my saved trials